Literature DB >> 21679311

MRD analysis and treatment outcome in three children with SET-NUP214-positive hematological malignancies.

W-J Li, L Cui, C Gao, X-X Zhao, S-G Liu, Y-P Xing, R-D Zhang, D-W Zhang, B Wang, Z-G Li, M-Y Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21679311     DOI： 10.1111/j.1751-553X.2011.01343.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN： 1751-5521            Impact factor:   2.877


× No keyword cloud information.
  3 in total

1.  [Analysis of the clinical characteristics of 24 cases of hematological malignancies with SET-NUP214 fusion gene].

Authors:  S M Chen; W J Song; Y Z Qin; Z Wang; H Dang; Y Shi; Q He; Q Jiang; H Jiang; X J Huang; Y Y Lai
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-06-14

2.  NUP214 fusion genes in acute leukemia (Review).

Authors:  Min-Hang Zhou; Qing-Ming Yang
Journal:  Oncol Lett       Date:  2014-06-18       Impact factor: 2.967

3.  Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review.

Authors:  Na Lin; Zhenghua Liu; Yan Li; Xiaojing Yan; Lei Wang
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.